Reverse engineering B. Schlosseri developmental-regulated cell death programs for cancer immunotherapy

Keyphrases

• Fusion Protein 100%
• Cell Death Program 100%
• Reverse Engineering 100%
• Apoptotic Cells 100%
• Allogeneic 100%
• Cancer Immunotherapy 100%
• Adoptive Transfer 100%
• Regulated Cell Death 100%
• Family Members 50%
• Day 14 50%
• In Vitro Study 50%
• RNA Sequencing (RNA-seq) 50%
• Recombinant 50%
• Binding Protein 50%
• Cytotoxicity 50%
• Marine Species 50%
• Specific Receptor 50%
• Transfer Research 50%
• Minimal Impact 50%
• Chimera 50%
• Tumor Immunity 50%
• Cell Recognition 50%
• Takeovers 50%
• Expression Profiling 50%
• Cell Removal 50%
• Zooids 50%
• Morula Cells 50%
• MerTK 50%
• Phagocytic Receptor 50%
• Engineering Cell 50%
• Removal Function 50%
• Programmed Cell Death Pathway 50%
• RNA-seq Expression 50%
• IL-17C 50%
• IL-17 Family 50%

Biochemistry, Genetics and Molecular Biology

• Cell Death 100%
• Cancer Immunotherapy 100%
• Fusion Protein 66%
• Phosphatidylserine 66%
• RNA Sequence 33%
• In Vitro Study 33%
• Binding Protein 33%
• Interleukin 17 33%
• Cytokine 33%
• Cytotoxicity 33%
• RNA Sequencing 33%
• Marine Species 33%
• Morula 33%
• Zooid 33%
• Tumor Immunity 33%